ORN Stock UPDATES Orion Marine Group Inc (ORN) 9.79 10/30/2014

New Post Public Reply Private Reply Replies (0) Message Board

Oct 30, 2014 at 4:03 AM

Orion Marine Group Inc (ORN) 9.79 $ORN

Orion Marine Shares Down 20.3% Since SmarTrend's Sell Call (ORN)
Comtex SmarTrend(R) - Thu Oct 23, 9:20AM CDT
SmarTrend identified a Downtrend for Orion Marine (NYSE:ORN) on April 30th, 2014 at $11.60. In approximately 6 months, Orion Marine has returned 20.31% as of today's recent price of $9.24.
ORN: 9.79 (+0.13)

Orion Marine Group Schedules Announcement of Third Quarter 2014 Results
GlobeNewswire - Fri Oct 17, 3:15PM CDT
Orion Marine Group, Inc. (NYSE:ORN) (the "Company"

today announced it will release its financial results for the third quarter of 2014 on Thursday, October 30, 2014, at approximately 5:00 a.m. Eastern Time/4:00 a.m. Central Time. The Company will conduct a telephone briefing at 10:00 a.m. Eastern Time/9:00 a.m. Central Time on Thursday, October 30, 2014, to discuss its results for the third quarter of 2014.
ORN: 9.79 (+0.13)

Orion Marine Down 21.9% Since SmarTrend Downtrend Call (ORN)
Comtex SmarTrend(R) - Wed Oct 15, 5:29PM CDT
SmarTrend identified a Downtrend for Orion Marine (NYSE:ORN) on April 30th, 2014 at $11.60. In approximately 6 months, Orion Marine has returned 21.95% as of today's recent price of $9.05.
ORN: 9.79 (+0.13)

16.2% Return Seen to Date on SmarTrend Orion Marine Call (ORN)
Comtex SmarTrend(R) - Wed Oct 08, 5:00PM CDT
SmarTrend identified a Downtrend for Orion Marine (NYSE:ORN) on April 30th, 2014 at $11.60. In approximately 5 months, Orion Marine has returned 16.17% as of today's recent price of $9.72.
ORN: 9.79 (+0.13)

ORN, PAGG, THD, NTGR, ALR, MHH Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Oct 08, 3:18AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Orsa Ventures Corp (NYSE:ORN), PowerShares Global Agriculture Portfolio (NASDAQ

AGG), iShares MSCI Thailand Investable Market Index Fund (NYSE:THD), NETGEAR Inc (NASDAQ:NTGR), ALERE INC (NYSE:ALR), Mastech Holdings Inc (NYSE:MHH) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
ORN: 9.79 (+0.13), THD: 81.98 (-0.84), NTGR: 33.50 (-0.38), MHH: 11.85 (+0.06), ALR: 38.57 (-0.55), PAGG: 28.71 (-0.04)

Orion Marine Shares Down 14.7% Since SmarTrend's Sell Call (ORN)
Comtex SmarTrend(R) - Wed Oct 01, 11:16AM CDT
SmarTrend identified a Downtrend for Orion Marine (NYSE:ORN) on April 30th, 2014 at $11.60. In approximately 5 months, Orion Marine has returned 14.70% as of today's recent price of $9.89.
ORN: 9.79 (+0.13)

Orion Marine Group Updates Investors
GlobeNewswire - Thu Sep 25, 4:00AM CDT
Orion Marine Group, Inc. (NYSE:ORN) (the "Company"

, a heavy civil marine contractor serving the infrastructure sector, today is providing it's investors an update on the Company's outlook and end markets.
ORN: 9.79 (+0.13)

Shares of ORN Down 12.7% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Sep 17, 9:25AM CDT
SmarTrend identified a Downtrend for Orion Marine (NYSE:ORN) on April 30th, 2014 at $11.60. In approximately 5 months, Orion Marine has returned 12.72% as of today's recent price of $10.12.
ORN: 9.79 (+0.13)

Orion Marine Group Presenting at the 8th Annual Imperial Capital Global Opportunities Conference
GlobeNewswire - Wed Sep 10, 3:15PM CDT
Orion Marine Group, Inc. (NYSE:ORN) (the "Company"

, a leading heavy civil marine contractor serving the infrastructure sector, today announced Chris DeAlmeida, Orion Marine Group's Chief Financial Officer will be presenting at the 2014 8 Annual Imperial Capital Global Opportunities Conference on Tuesday, September 18, 2014. The presentation is scheduled to begin at 1:45 p.m. (ET)/12:45 p.m. (CT).
ORN: 9.79 (+0.13)

9.8% Return Seen to Date on SmarTrend Orion Marine Call (ORN)
Comtex SmarTrend(R) - Tue Sep 09, 5:20PM CDT
SmarTrend identified a Downtrend for Orion Marine (NYSE:ORN) on April 30th, 2014 at $11.60. In approximately 4 months, Orion Marine has returned 9.79% as of today's recent price of $10.46.
ORN: 9.79 (+0.13)

Orion Marine Down 12.4% Since SmarTrend Downtrend Call (ORN)
Comtex SmarTrend(R) - Mon Aug 25, 5:04PM CDT
SmarTrend identified a Downtrend for Orion Marine (NYSE:ORN) on April 30th, 2014 at $11.60. In approximately 4 months, Orion Marine has returned 12.38% as of today's recent price of $10.16.
ORN: 9.79 (+0.13)

Orion Marine Group Appoints James L. Rose as Chief Operating Officer
GlobeNewswire - Mon Aug 18, 4:17PM CDT
Orion Marine Group, Inc. (NYSE:ORN) (the "Company"

, a leading heavy civil marine contractor serving the infrastructure sector, today announced the appointment of James L. Rose to the position of Executive Vice President and Chief Operating Officer.
ORN: 9.79 (+0.13), GVA: 35.76 (+0.01)

Orion Marine Has Returned 9.8% Since SmarTrend Recommendation (ORN)
Comtex SmarTrend(R) - Mon Aug 18, 11:21AM CDT
SmarTrend identified a Downtrend for Orion Marine (NYSE:ORN) on April 30th, 2014 at $11.60. In approximately 4 months, Orion Marine has returned 9.83% as of today's recent price of $10.46.
ORN: 9.79 (+0.13)

Orion Marine Down 9.0% Since SmarTrend Downtrend Call (ORN)
Comtex SmarTrend(R) - Mon Aug 11, 11:01AM CDT
SmarTrend identified a Downtrend for Orion Marine (NYSE:ORN) on April 30th, 2014 at $11.60. In approximately 3 months, Orion Marine has returned 9.01% as of today's recent price of $10.55.
ORN: 9.79 (+0.13)

Orion Marine Group, Inc. Reports Second Quarter 2014 Results; Reports Record Backlog
GlobeNewswire - Thu Jul 31, 4:00AM CDT
Orion Marine Group, Inc. (NYSE:ORN) (the "Company"

, a heavy civil marine contractor, today reported a net loss for the three months ended June 30, 2014, of $1.2 million ($0.04 diluted loss per share). These results compare to a net profit of $0.2 million ($0.01 diluted earnings per share) for the same period a year ago.
ORN: 9.79 (+0.13)

Orion Marine Group Schedules Announcement of Second Quarter 2014 Results
GlobeNewswire - Wed Jul 23, 4:48PM CDT
Orion Marine Group, Inc. (NYSE:ORN) (the "Company"

today announced it will release its financial results for the second quarter of 2014 on Thursday, July 31, 2014, at approximately 5:00 a.m. Eastern Time/4:00 a.m. Central Time. The Company will conduct a telephone briefing at 10:00 a.m. Eastern Time/9:00 a.m. Central Time on Thursday, July 31, 2014, to discuss its results for the second quarter of 2014.
ORN: 9.79 (+0.13)

Granite (GVA) Appoints New COO to Drive Operations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 15, 4:40PM CDT
Granite (GVA) has appointed Christopher S. Miller as the chief operating officer.
ORN: 9.79 (+0.13), JEC: 47.19 (-0.21), GVA: 35.76 (+0.01), BZH: 17.95 (-0.18)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...